Zoetis Presents Folds of Honor With $195,000 Donation

Veteran’s Day weekend tailgate event brings year-to-date contribution to $487,000

PARSIPPANY, N.J. — Nov. 16, 2022 — A tailgate event in Stillwater, Oklahoma, at the Oklahoma State University vs Iowa State University football game took on a special meaning as representatives from Zoetis presented the company’s third donation to Folds of Honor. Based in Owasso, Oklahoma, Folds of Honor provides academic scholarships to the spouses and children of men and women who have fallen or been disabled while serving in the U.S. armed forces or as first responders.

Zoetis made this donation to Folds of Honor based upon each bottle of select Zoetis products purchased by beef and dairy producers from across the country. Representatives from the U.S. cattle division presented a donation of $195,000 to Ben Leslie, chief impact officer for Folds of Honor.

“Zoetis is grateful for the continued support of our customers. Folds of Honor has put our year-to-date contribution of $487,000 to work helping fund scholarship programs for the families of the heroes that help protect our communities and our freedoms,” said Jared Shriver, senior vice president of U.S. Cattle and Pork at Zoetis.

Folds of Honor was founded in 2007 by Lt Col Dan Rooney, an F-16 fighter pilot who served three combat tours of duty in Iraq. Folds of Honor is proud to have awarded nearly 44,000 scholarships in all 50 states.

“The support of Zoetis allows us to continue providing more life-changing educational opportunities for the families of our military heroes,” said Leslie with Folds of Honor.

As host of the tailgate event on Veteran’s Day weekend, Tom White, area business manager with Zoetis, said Folds of Honor is an organization their customers believe in. “Our customers are patriotic, loyal supporters of armed forces and first responders,” said White. “Many of them have family members that have served, or have lost family members in the service, so Folds of Honor hits close to home for them.”

Zoetis is committed to supporting the legacy of leaders in agriculture and communities across the United States. Zoetis will donate $1 per bottle of sales of select cattle anti-infectives through Dec. 31, 2022, to Folds of Honor. Qualifying products are Draxxin® (tulathromycin injection) Injectable Solution, Draxxin® KP (tulathromycin and ketoprofen injection) Injectable Solution, Excede® (ceftiofur crystalline free acid) Sterile Suspension and Excenel® RTU EZ (ceftiofur hydrochloride) Sterile Suspension.

For more information about Folds of Honor, visit www.foldsofhonor.org. If you would like to learn more about how Zoetis works with Folds of Honor, contact your local Zoetis representative or visit www.zoetisus.com/misc/folds-of-honor-faq.aspx.

IMPORTANT SAFETY INFORMATION: Draxxin has a pre-slaughter withdrawal time of 18 days in cattle. Do not use in female dairy cattle 20 months of age or older. Do not use in animals known to be hypersensitive to the product. See full Prescribing Information, here.

IMPORTANT SAFETY INFORMATION:  Draxxin KP has a pre-slaughter withdrawal time of 18 days in cattle.  Not for use in female dairy cattle 1 year of age or older, including dry dairy cows.  Not for use in beef calves less than 2 months of age, dairy calves, and veal calves. A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in animals previously found to be hypersensitive to tulathromycin and ketoprofen.  See full Prescribing Information, here.

IMPORTANT SAFETY INFORMATION: People with known hypersensitivity to penicillin or cephalosporins should avoid exposure to Excede. Excede is contraindicated in animals with known allergy to ceftiofur or to the ß-lactam group (penicillins and cephalosporins) of antimicrobials. Inadvertent intra-arterial injection is possible and fatal. Do not use in calves to be processed for veal. Pre-slaughter withdrawal time is 13 days following the last dose. See full Prescribing Information, See full Prescribing Information, here.

IMPORTANT SAFETY INFORMATION: People with known hypersensitivity to penicillin or cephalosporins should avoid exposure to Excenel RTU EZ. Do not use in animals found to be hypersensitive to the product. Do not slaughter cattle for 4 days following last treatment. Do not use in calves to be processed for veal. See full Prescribing Information, here.

About Zoetis

As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After 70 years innovating ways to predict, prevent, detect and treat animal illness, Zoetis continues to stand by those raising and caring for animals worldwide, from livestock farmers to veterinarians and pet owners. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of $7.8 billion in 2021 with approximately 12,100 employees. For more, visit zoetis.com

NOTE: A high-resolution photo of the check presentation is available upon request.

All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted.© 2022 Zoetis Services LLC. All rights reserved. GCA-00695

Media Contacts:

Clint Mefford
Zoetis
816-261-4868
clint.mefford@zoetis.com

Lori Maude
Bader Rutter
303-809-3789
lmaude@bader-rutter.com

CONTACT US

1-888-963-8471

Mon–Fri, 8:30am–8:00pm ET

This site is intended for U.S. Animal Healthcare Professionals. The product information provided in this site is intended only for residents of the United States. The products discussed herein may not have marketing authorization or may have different product labeling in different countries. The animal health information contained herein is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. All decisions regarding the care of a veterinary patient must be made with an animal healthcare professional, considering the unique characteristics of the patient.

All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. ©2022 Zoetis Services LLC. All rights reserved.